Zn-alpha 2-glycoprotein levels in breast cancer cytosols and correlation with clinical, histological and biochemical parameters

Eur J Cancer. 1993;29A(9):1256-60. doi: 10.1016/0959-8049(93)90068-q.

Abstract

Zn-alpha 2-glycoprotein (Zn-alpha 2-gp), a protein present at high levels in breast cyst fluid, has been measured in 104 breast tumour cytosols by using an immunoenzymatic assay. Concentrations of Zn-alpha 2-gp ranged from 0 to 23.5 micrograms/mg of total soluble protein, with an average value of 2.4 micrograms/mg. There was no significant correlation between Zn-alpha 2-gp and menopausal status, tumour size or lymph node involvement, or between this protein and biochemical parameters such as oestrogen receptor, cathepsin D or pS2 levels. However, there was a significant association between Zn-alpha 2-gp and histological grade of tumours, with higher Zn-alpha 2-gp levels in well-differentiated tumours (mean 4.6 micrograms/mg) than in moderately (1.8 micrograms/mg) or poorly (0.9 micrograms/mg) differentiated tumours. On the basis of these results, we propose that Zn-alpha 2-gp may be considered as a biochemical marker of differentiation in breast cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / pathology
  • Cytosol / chemistry*
  • Female
  • Glycoproteins / analysis*
  • Humans
  • Lymphatic Metastasis
  • Menopause / metabolism
  • Middle Aged
  • Neoplasm Proteins / analysis*
  • Prognosis
  • Seminal Plasma Proteins*
  • Zn-Alpha-2-Glycoprotein

Substances

  • Biomarkers, Tumor
  • Glycoproteins
  • Neoplasm Proteins
  • Seminal Plasma Proteins
  • Zn-Alpha-2-Glycoprotein